These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
176 related items for PubMed ID: 12705802
1. Neovascularization; its molecular mechanism and biology. Sato Y. Intern Med; 2003 Mar; 42(3):295-7. PubMed ID: 12705802 [No Abstract] [Full Text] [Related]
2. [Vascular endothelial growth factor and nitric oxide]. Liu YQ, Zhou AR. Sheng Li Ke Xue Jin Zhan; 2000 Jan; 31(1):69-71. PubMed ID: 12532773 [No Abstract] [Full Text] [Related]
3. Nitric oxide and angiogenic activity of endothelial cells: direct or VEGF-dependent effect? Dulak J, Józkowicz A. Cardiovasc Res; 2002 Dec; 56(3):487-8; author reply 489-91. PubMed ID: 12445890 [No Abstract] [Full Text] [Related]
4. [Role of VEGF in the cellular response to injury]. Alvarez-Arroyo MV, Yagüe S, González-Pacheco FR, Castilla MA, Suzuki Y, Jiménez S, Deudero JJ, Neria F, Velasco L, Caramelo C. Nefrologia; 2003 Dec; 23 Suppl 3():54-7. PubMed ID: 12901194 [No Abstract] [Full Text] [Related]
6. Molecular framework for angiogenesis: a complex web of interactions between extravasated plasma proteins and endothelial cell proteins induced by angiogenic cytokines. Senger DR. Am J Pathol; 1996 Jul; 149(1):1-7. PubMed ID: 8686733 [No Abstract] [Full Text] [Related]
8. Pro-angiogenic activities of CYR61 (CCN1) mediated through integrins alphavbeta3 and alpha6beta1 in human umbilical vein endothelial cells. Leu SJ, Lam SC, Lau LF. J Biol Chem; 2002 Nov 29; 277(48):46248-55. PubMed ID: 12364323 [Abstract] [Full Text] [Related]
9. Molecular control of capillary growth in skeletal muscle. Haas TL. Can J Appl Physiol; 2002 Oct 29; 27(5):491-515. PubMed ID: 12429896 [Abstract] [Full Text] [Related]
10. Vascular endothelial growth factor, a potent and selective angiogenic agent. Thomas KA. J Biol Chem; 1996 Jan 12; 271(2):603-6. PubMed ID: 8557658 [No Abstract] [Full Text] [Related]
11. [Autocrine regulation of angiogenesis]. Yonekura H. Seikagaku; 2001 Jan 12; 73(1):27-31. PubMed ID: 11244738 [No Abstract] [Full Text] [Related]
12. Vascular endothelial growth factor and diabetic nephropathy. Gudehithlu KP, Singh AK. Int J Artif Organs; 1999 May 12; 22(5):297-9. PubMed ID: 10467926 [No Abstract] [Full Text] [Related]
13. The molecular perspective: VEGF and angiogenesis. Goodsell DS. Oncologist; 2002 May 12; 7(6):569-70. PubMed ID: 12490744 [No Abstract] [Full Text] [Related]
14. Angiogenesis and angiogenesis inhibition: an overview. Folkman J. EXS; 1997 May 12; 79():1-8. PubMed ID: 9002217 [No Abstract] [Full Text] [Related]
15. [Transactivation of the vascular endothelial growth factor receptor KDR/Flk-1 by the bradykinin B2 receptor induces an angiogenic phenotype in human cultured coronary endothelial cells]. Miura S, Fujino M, Tanigawa H, Matsuo Y, Saku K. Nihon Yakurigaku Zasshi; 2002 Nov 12; 120(1):104P-105P. PubMed ID: 12491796 [Abstract] [Full Text] [Related]
16. [Effects of statins on angiogenesis and vasculogenesis]. Llevadot J, Asahara T. Rev Esp Cardiol; 2002 Aug 12; 55(8):838-44. PubMed ID: 12199980 [Abstract] [Full Text] [Related]
17. Integrating the VEGF signals leading to actin-based motility in vascular endothelial cells. Rousseau S, Houle F, Huot J. Trends Cardiovasc Med; 2000 Nov 12; 10(8):321-7. PubMed ID: 11369257 [Abstract] [Full Text] [Related]
18. [Vascular endothelial growth factor--fundamental research and experimental study in plastic surgery]. Huang CY, Shen ZY. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2002 Jan 12; 16(1):64-9. PubMed ID: 11826659 [Abstract] [Full Text] [Related]
19. Molecular mechanisms of retinal neovascularization in diabetic retinopathy. Takagi H. Intern Med; 2003 Mar 12; 42(3):299-301. PubMed ID: 12705804 [No Abstract] [Full Text] [Related]